Posted inBiotechnology
Roche pens backloaded $2B deal with Atavistik to discover allosteric CVRM drugs
Roche has penned a backloaded $2 billion deal with hematology biotech Atavistik Bio to develop allosteric small molecules for cardiometabolic…








